ArticleTherapeutic advances in medical oncology2024

A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).

Sun Kyung Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.